Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1957 2
1958 2
1963 1
1965 1
1967 4
1968 2
1969 3
1970 2
1971 1
1972 2
1973 7
1974 5
1975 9
1976 5
1977 7
1978 4
1979 8
1980 1
1981 6
1982 8
1983 4
1984 9
1985 3
1986 6
1987 10
1988 12
1989 8
1990 11
1991 10
1992 7
1993 9
1994 5
1995 3
1996 7
1997 1
1998 4
1999 2
2000 4
2001 1
2002 6
2003 2
2004 4
2005 2
2006 5
2007 5
2008 10
2009 8
2010 17
2011 12
2012 20
2013 24
2014 31
2015 40
2016 40
2017 38
2018 47
2019 34
2020 30
2021 44
2022 43
2023 32
2024 32
2025 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

687 results

Results by year

Filters applied: . Clear all
Page 1
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CCS, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M. Krakow EF, et al. Among authors: cunningham tm. Blood. 2024 Sep 5;144(10):1069-1082. doi: 10.1182/blood.2024024105. Blood. 2024. PMID: 38683966 Free PMC article. Clinical Trial.
Creation of de novo cryptic splicing for ALS and FTD precision medicine.
Wilkins OG, Chien MZYJ, Wlaschin JJ, Barattucci S, Harley P, Mattedi F, Mehta PR, Pisliakova M, Ryadnov E, Keuss MJ, Thompson D, Digby H, Knez L, Simkin RL, Diaz JA, Zanovello M, Brown AL, Darbey A, Karda R, Fisher EMC, Cunningham TJ, Le Pichon CE, Ule J, Fratta P. Wilkins OG, et al. Among authors: cunningham tj. Science. 2024 Oct 4;386(6717):61-69. doi: 10.1126/science.adk2539. Epub 2024 Oct 3. Science. 2024. PMID: 39361759 Free PMC article.
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.
Haydar D, Ibañez-Vega J, Crawford JC, Chou CH, Guy CS, Meehl M, Yi Z, Perry S, Laxton J, Cunningham T, Langfitt D, Vogel P, DeRenzo C, Gottschalk S, Roussel MF, Thomas PG, Krenciute G. Haydar D, et al. Among authors: cunningham t. Cancer Res Commun. 2023 Dec 1;3(12):2430-2446. doi: 10.1158/2767-9764.CRC-23-0424. Cancer Res Commun. 2023. PMID: 37971169 Free PMC article.
Beware the Jackalopes.
Cunningham TV. Cunningham TV. Am J Bioeth. 2022 Aug;22(8):75-77. doi: 10.1080/15265161.2022.2089283. Am J Bioeth. 2022. PMID: 35917423 No abstract available.
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironment.
Adeshakin AO, Shi H, Perry SS, Sheppard H, Nguyen P, Sun X, Zhou P, Métais JY, Cunningham T, Anil KC, Tian L, Peche V, Prater MS, Langfitt DM, Pruett-Miller SM, Yustein JT, Krenciute G, DeRenzo C, Chi H, Gottschalk S. Adeshakin AO, et al. Among authors: cunningham t. bioRxiv [Preprint]. 2025 May 23:2025.05.20.650777. doi: 10.1101/2025.05.20.650777. bioRxiv. 2025. PMID: 40475601 Free PMC article. Preprint.
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.
Masana L, Zambon A, Schmitt CP, Taylan C, Driemeyer J, Cohen H, Buonuomo PS, Alashwal A, Al-Dubayee M, Kholaif N, Diaz-Diaz JL, Maatouk F, Martinez-Hervas S, Mangal B, Löwe S, Cunningham T. Masana L, et al. Among authors: cunningham t. Lancet Diabetes Endocrinol. 2024 Dec;12(12):880-889. doi: 10.1016/S2213-8587(24)00233-X. Epub 2024 Oct 16. Lancet Diabetes Endocrinol. 2024. PMID: 39426393 Clinical Trial.
eIF4A inhibition: ready for primetime?
Cunningham TA, Chapman E, Schatz JH. Cunningham TA, et al. Oncotarget. 2018 Oct 30;9(85):35515-35516. doi: 10.18632/oncotarget.26268. eCollection 2018 Oct 30. Oncotarget. 2018. PMID: 30473746 Free PMC article. No abstract available.
Morbidities in the ultra-athlete and marathoner.
Cunningham TC, Maghrabi K, Sanatani S. Cunningham TC, et al. Cardiol Young. 2017 Jan;27(S1):S94-S100. doi: 10.1017/S1047951116002304. Cardiol Young. 2017. PMID: 28084966 Review.
Azathioprine-induced shock.
Cunningham T, Barraclough D, Muirden K. Cunningham T, et al. Br Med J (Clin Res Ed). 1981 Sep 26;283(6295):823-4. doi: 10.1136/bmj.283.6295.823-a. Br Med J (Clin Res Ed). 1981. PMID: 6794715 Free PMC article. No abstract available.
687 results